Sacubitril-valsartan (ARNI)

Are you sure? Dr. Taylor reminds you that therapy with an angiotensin receptor-neprilysin inhibitor (ARNI) is very beneficial for the treatment of chronic heart failure. Since Mrs. Reed was diagnosed with heart failure two years ago, she is likely already taking a drug that inhibits the RAAS pathway. The benefits of using an ARNI in the acute setting are not clear though. 

Since this is a virtual patient, you may go back and try again.

  • Furosemide (loop diuretic)

Map: Faith Reed_ORU_1 (1090)
Node: 20590
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway

  • The result
  • Simvastatin
  • The result
  • Μη φαρμακευτικές θεραπείες
  • Tranexamic acid (antidote to fibrinolytic)
  • (1) prophase, (2) interphase, (3) telophase, (4) prometaphase, (5) metaphase and (6) anaphase
  • Observation under the microscope (plant cell)
  • Νιώθει καλύτερα και σταματά να παίρνει τα φάρμακά της
  • Your detail explanation
  • The reason
  • All areas tested are contaminated.
  • Secvențierea genomului
  • Option 2
  • EMB
  • Protein Synthesis
  • Παραπομπή σε παθολόγο.
  • Getting worse
  • They will discuss about going on vacation.
  • new node
  • History of Medication Compliance
  • Sacubitril-valsartan (ARNI)

Reminder

FINISH

Time is up